Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Completed 2Unknown 1

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Head & Neck 5Thoracic 3Gastrointestinal 3Sarcoma 2Genitourinary 1CNS 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Neoplasm, Residual 1

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Adjuvants, Pharmaceutic × Thoracic × Clear all
NCT05167604 2021-12-22

Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC

Tang-Du Hospital

Unknown
150 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm, Residual

NCT01949701 2019-03-19

Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*02 Disease Controlled Advanced Non-small Cell Lung Cancer

Shiga University

Phase 1/2 Completed
6 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01950156 2019-03-19

Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 Disease Controlled Advanced Non-small Cell Lung Cancer

Shiga University

Phase 1/2 Completed
6 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡